ANL 24.00 Increased By ▲ 0.20 (0.84%)
ASC 16.45 Increased By ▲ 0.05 (0.3%)
ASL 22.78 Increased By ▲ 0.13 (0.57%)
BOP 8.63 Increased By ▲ 0.25 (2.98%)
BYCO 8.93 Increased By ▲ 0.12 (1.36%)
FCCL 18.70 Increased By ▲ 0.23 (1.25%)
FFBL 24.66 Increased By ▲ 0.06 (0.24%)
FFL 18.28 Increased By ▲ 0.23 (1.27%)
FNEL 8.55 Increased By ▲ 0.01 (0.12%)
GGGL 22.45 Increased By ▲ 0.15 (0.67%)
GGL 44.40 Increased By ▲ 0.45 (1.02%)
HUMNL 7.15 Decreased By ▼ -0.02 (-0.28%)
JSCL 21.92 Increased By ▲ 0.34 (1.58%)
KAPCO 38.01 Decreased By ▼ -0.09 (-0.24%)
KEL 3.63 Increased By ▲ 0.03 (0.83%)
MDTL 3.16 Increased By ▲ 0.09 (2.93%)
MLCF 37.23 Increased By ▲ 0.75 (2.06%)
NETSOL 157.20 Decreased By ▼ -0.55 (-0.35%)
PACE 6.13 Increased By ▲ 0.12 (2%)
PAEL 31.92 Increased By ▲ 0.27 (0.85%)
PIBTL 9.55 Increased By ▲ 0.08 (0.84%)
POWER 8.11 Increased By ▲ 0.07 (0.87%)
PRL 21.10 Increased By ▲ 0.12 (0.57%)
PTC 10.57 Increased By ▲ 0.19 (1.83%)
SILK 1.73 Increased By ▲ 0.04 (2.37%)
SNGP 43.76 Increased By ▲ 0.01 (0.02%)
TELE 22.95 Increased By ▲ 0.25 (1.1%)
TRG 178.10 Increased By ▲ 2.19 (1.24%)
UNITY 36.57 Decreased By ▼ -0.40 (-1.08%)
WTL 3.37 Increased By ▲ 0.04 (1.2%)
BR100 5,053 Increased By ▲ 27.22 (0.54%)
BR30 24,997 Increased By ▲ 223.5 (0.9%)
KSE100 47,114 Increased By ▲ 193.11 (0.41%)
KSE30 18,700 Increased By ▲ 41.56 (0.22%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
27,072
6824hr
Pakistan Cases
1,218,749
2,92824hr
5.08% positivity
Sindh
448,658
Punjab
419,423
Balochistan
32,707
Islamabad
103,720
KPK
170,391
World

J&J's says its Covid-19 vaccine effectively combats Delta variant

  • The antibodies and immune system cells in the blood of eight people vaccinated with the J&J jab effectively neutralized the Delta strain
02 Jul 2021

WASHINGTON: Johnson and Johnson's single-shot Covid-19 vaccine is effective against the highly contagious Delta variant, with an immune response lasting at least eight months, the company said Thursday.

The antibodies and immune system cells in the blood of eight people vaccinated with the J&J jab effectively neutralized the Delta strain, which was first identified in India, researchers found.

A second study with 20 vaccinated patients at Boston's Beth Israel Medical Center had similar results.

The data was sent to bioRxiv, a free online site for unpublished scientific preprints where authors "are able to make their findings immediately available to the scientific community and receive feedback on draft manuscripts before they are submitted to journals," according to the site.

"We believe that our vaccine offers durable protection against COVID-19 and elicits neutralizing activity against the Delta variant," said Paul Stoffels, J&J's chief scientific officer, in a company statement.

Mathai Mammen, head of Janssen Research & Development at Johnson & Johnson, said that data "for the eight months studied so far" shows that J&J's single-shot vaccine "generates a strong neutralizing antibody response that does not wane; rather, we observe an improvement over time."

The Delta variant tore through in India in April and May and has since spread around the world. A report by the European Union's disease control agency ECDC estimated the more contagious strain could account for 90 percent of new cases in the EU by the end of August.

Comments

Comments are closed.